Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2003
09/16/2003US6620435 Compositions for topical application of therapeutic agents
09/16/2003US6620429 Free active substance base is liberated, during the manufacture of the system, from active substance salts by conversion with a basic alkaline metal salt
09/16/2003US6620415 Parkinson's disease treatment
09/16/2003US6620407 Solid polymer particles having hydrophilic and lipophilic properties
09/16/2003US6620382 Method and compositions for treatment of cancers
09/16/2003CA2130577C Combinations of ace inhibitors and diuretics
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
09/12/2003WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003WO2003074084A1 A pharmaceutical composition
09/12/2003WO2003074083A1 Combination therapies for treating methylthioadenosine phosphorylase deficient cells
09/12/2003WO2003074082A1 Formulations and methods of using nitric oxide mimetics in cancer treatment
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074072A1 Methods and compositions for the treatment of ischemia
09/12/2003WO2003074067A1 Compositions of and derived from strawberry and raspberry and therapeutic uses therefor
09/12/2003WO2003074057A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003WO2003074055A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003WO2003074045A1 Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor
09/12/2003WO2003074043A1 Body temperature elevating agents
09/12/2003WO2003074040A1 Compositions for ameliorating fecal properties
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003074037A1 Treatment of female sexual dysfunction
09/12/2003WO2003074036A1 Novel formulation
09/12/2003WO2003074034A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
09/12/2003WO2003074027A2 Self emulsifying drug delivery systems for poorly soluble drugs
09/12/2003WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
09/12/2003WO2003074023A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
09/12/2003WO2003074002A2 Methods of treating pin1 associated disorders
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073989A2 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073916A2 Immune regulation
09/12/2003WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003039559B1 Pharmaceutical combinatons comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003028710A3 Compounds for reducing excessive intake of food
09/12/2003WO2003017932B1 Compositions and methods for targeting cerebral circulation and treatment of headache
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002058732B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
09/12/2003WO2002056884A3 Treatment of malaria with farnesyl protein transferase inhibitors
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
09/12/2003WO2002005853A3 Compositions containing alpha-2-adrenergic agonist components
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478612A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003CA2478425A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
09/12/2003CA2478424A1 Self emulsifying drug delivery systems for poorly soluble drugs
09/12/2003CA2478145A1 Formulations and methods of using nitric oxide mimetics in cancer treatment
09/12/2003CA2478133A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2477795A1 Nucleoside 5'-monophosphate mimics and their prodrugs
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477422A1 Combination therapies for treating methylthioadenosine phosphorylase deficient cells
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2477392A1 Methods for treating diseases related to intraocular pressure
09/12/2003CA2477387A1 Treatment of female sexual dysfunction
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2477075A1 Pharmaceutical and cosmetic compositions comprising plgf-1
09/11/2003WO2003074075A1 Pharmaceutical and cosmetic compositions comprising plgf-1
09/11/2003WO2003074024A1 Formoterol superfine formulation
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030171773 Methods for aneurysm repair
09/11/2003US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171496 Drug delivery compositions and medical devices containing block copolymer
09/11/2003US20030171441 Therapy for drug resistant virus
09/11/2003US20030171438 Method for treatment of external secretion disorders
09/11/2003US20030171433 Mixture containing fatty acid; adjust fat concentration
09/11/2003US20030171426 Antilipemic agents; atherosclerosis; anticholesterol agents; cardiovascular disorders
09/11/2003US20030171420 Using a thiolactomycin compound as parasiticide
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171414 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171407 Synergistic mixture of insulin secretory stimulant and enzyme inhibitor; hypoglycemic agents, antidiabetic agents
09/11/2003US20030171406 Medicinal compositions containing propenone derivatives
09/11/2003US20030171405 Reducing concentration of glucose, triglycerides; antidiabtic agents
09/11/2003US20030171402 Method of treating neutrophil-related diseases with topical anesthetics
09/11/2003US20030171397 For drug resistance tumors; synergistic mixture of sigma a antagonist and antitumor drug; controlling dosage
09/11/2003US20030171386 Small molecules for the treatment of abnormal cell growth
09/11/2003US20030171385 Synergistic enhancement of cognitive ability
09/11/2003US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents
09/11/2003US20030171379 Skin disorders; antiarthritic agents; Crohn's disease
09/11/2003US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus
09/11/2003US20030171363 Non-nucleoside reverse transcriptase inhibitors
09/11/2003US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement
09/11/2003US20030171348 Diagnosis and management of infection caused by Chlamydia
09/11/2003US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24.
09/11/2003US20030171340 Treating antibiotic-resistant infections with a metal complex of tetracycline, glycylcycline, or quinolone antibiotics, or administering a metal compound and the antibiotic together for in situ formation of the complex
1 ... 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 ... 1151